Mitotic kinesin inhibitors

Details Mitotic kinesin inhibitors Mitotic kinesin inhibitors

2004-12-15

2009-12-01

Rao, Deepak (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C544S319000

Reexamination Certificate

active

07625912

ABSTRACT:
The present invention relates to 2-phenylpyrimidinone compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.

REFERENCES:
patent: 4649198 (1987-03-01), Irikura et al.
patent: 4914104 (1990-04-01), Irikura et al.
patent: 6534658 (2003-03-01), Kojima et al.
patent: 6545004 (2003-04-01), Finer et al.
patent: 0 134 928 (1985-03-01), None
patent: 0 373 891 (1998-12-01), None
patent: 62-135473 (1987-06-01), None
patent: 6-49070 (1994-02-01), None
patent: WO 95/11235 (1995-04-01), None
patent: WO 01/30768 (2001-05-01), None
patent: WO 03/035076 (2003-05-01), None
patent: WO 03/035077 (2003-05-01), None
patent: WO 03/084938 (2003-10-01), None
patent: WO 03/094839 (2003-11-01), None
patent: WO 03/099211 (2003-12-01), None
patent: WO 2004/032879 (2004-04-01), None
patent: WO 2004/091547 (2004-10-01), None
Simone, Oncology: Introduction, Cecil Textbook of Medicine, 20thEdition, vol. 1, pp. 1004-1010, 1996.
Farrell et al., PubMed Abstract (J Biol Chem 277(19):17079-87), May 2002.
Arai et al., Caplus Abstrct 136:340653, 2002.
Shchavlinskii et al., Caplus Abstract 88:50401, 1978.
Staskun et al., Caplus Abstract 51:39274, 1957.
C.D. Cox, et al., Bioorganic & Medicinal Chem Ltrs. vol. 15, pp. 2041-2045 (2005).
W. Tao. Cell Cycle, vol. 4 (11), pp. 1495-1499 (2005).
K.D. Chu, et al. Proc. Am. Soc. Clin. Oncol., Abstract 525, p. 131 (2003).
R. Sakowicz, et al., Cancer Research, vol. 64, pp. 3276-3280 (2004).
W. Tao, et al., Cancer Cell, vol. 8, pp. 49-59 (2005).
J.C. Bennet, et al., Cecil Textbook of Medicine, 20th Ed., vol. 1, pp. 1004-1010 (1996).
Haque, et al., Cell Motility and Cytoskeleton, No. 58, pp. 10-16(2004).
Yildiz, et al., Trends in Cell Biology, vol. 15(7), pp. 112-120 (2005).
Maliga, et al., Chem. Biol., vol. 9(9), pp. 989-996 (2002).
Katou, Patent Abstracts of Japan, vol. 007, No. 095 (1983).
N. Katagiri, et al., Chemical and Pharmaceutical Bulletin, vol. 31 (7), pp. 2288-2295 (1983).
H. Uchida, et al., Bulletin of the Chem. Soc. of Japan, vol. 46(10) pp. 3277-3280 (1973).

Affiliated with

Also associated with

Rating

Mitotic kinesin inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mitotic kinesin inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mitotic kinesin inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4109473